NYU Chemistry graduate student Dan Yoo, in the Arora Lab, describes compounds that covalently target oncogenic Ras – a key driver of many cancers. Dan collaborated with the Bar-Sagi Lab, at the NYU School of Medicine, to show the potential of the designs to modulate Ras signaling in cancer cells. This work builds on the earlier efforts by alumnus Steve Joy who is now a research scientist at Michigan.